Showing results (211-220 of 273) with videos related to
Sort By:
Pageof 28
Beilstein Journal of Nanotechnology|July 11, 2022
Influence of thickness and morphology of MoS<sub>2</sub> on the performance of counter electrodes in dye-sensitized solar cellsLam Thuy Thi Mai, Hai Viet Le, Ngan Kim Thi Nguyen, et al.Geriatrics (Basel, Switzerland)|October 28, 2025
Prevalence and Associated Factors of Depression Among Elderly Hypertensive Patients in VietnamTuan Van Nguyen, Tung Son Vu, Thang Thien Tran, et al.Endoscopy International Open|July 3, 2015
Use of glasgow-blatchford bleeding score reduces hospital stay duration and costs for patients with low-risk upper GI bleedingMarc Girardin, David Bertolini, Saskia Ditisheim, et al.International Medical Case Reports Journal|November 18, 2024
Resuscitation from Respiratory Arrest Due to Life-Threatening Ventricular Arrhythmias in a Patient with Amitriptyline Intoxication: An Old Problem in a New EraTan Thanh Nguyen, Lac Duy Le, Thanh Tri Vu, et al.The Lancet. Infectious Diseases|June 9, 2014
Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week results of a randomised, open-label, phase 3b non-inferiority trialAnton Pozniak, Martin Markowitz, Anthony Mills, et al.Nature Communications|November 2, 2021
Ferroelectric 2D ice under graphene confinementHao-Ting Chin, Jiri Klimes, I-Fan Hu, et al.Langmuir : the ACS Journal of Surfaces and Colloids|August 10, 2018
Contactless Control of Local Surface Buckling in Photoaligned Gold/Liquid Crystal Polymer BilayersLaurens T de Haan, Timo J J Willigers, Levina E A Wijkhuijs, et al.HIV Clinical Trials|July 11, 2017
Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTIAnton Pozniak, Jason Flamm, Andrea Antinori, et al.HIV Clinical Trials|May 31, 2017
Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PIJose R Arribas, Edwin DeJesus, Jan van Lunzen, et al.Journal of Biomolecular Structure & Dynamics|March 30, 2023
Targeting Olokizumab-Interleukin 6 interaction interface to discover novel IL-6 inhibitorsQue-Huong Tran, Hoang-Nhi Cao, Dac-Nhan Nguyen, et al.Pageof 28